133 related articles for article (PubMed ID: 35421765)
21. Anti-tumoral Titanium
Zhao T; Wang P; Zhang X; Liu N; Zhao W; Zhang Y; Yuan P; Li S; Yang M; Yang Z; Huhn T
Curr Top Med Chem; 2023; 23(19):1835-1849. PubMed ID: 37151173
[TBL] [Abstract][Full Text] [Related]
22. In Vivo Anticancer Activity of a Nontoxic Inert Phenolato Titanium Complex: High Efficacy on Solid Tumors Alone and Combined with Platinum Drugs.
Ganot N; Briaitbard O; Gammal A; Tam J; Hochman J; Tshuva EY
ChemMedChem; 2018 Nov; 13(21):2290-2296. PubMed ID: 30203598
[TBL] [Abstract][Full Text] [Related]
23. Unexpected influence of stereochemistry on the cytotoxicity of highly efficient Ti(IV) salan complexes: new mechanistic insights.
Manna CM; Armony G; Tshuva EY
Chemistry; 2011 Dec; 17(50):14094-103. PubMed ID: 22076809
[TBL] [Abstract][Full Text] [Related]
24. Titanium Tackles the Endoplasmic Reticulum: A First Genomic Study on a Titanium Anticancer Metallodrug.
Miller M; Mellul A; Braun M; Sherill-Rofe D; Cohen E; Shpilt Z; Unterman I; Braitbard O; Hochman J; Tshuva EY; Tabach Y
iScience; 2020 Jul; 23(7):101262. PubMed ID: 32585595
[TBL] [Abstract][Full Text] [Related]
25. HPLC-ICPMS and stable isotope-labeled approaches to assess quantitatively Ti(IV) uptake by transferrin in human blood serum.
Sarmiento-González A; Ruiz Encinar J; Cantarero-Roldán AM; Marchante-Gayón JM; Sanz-Medel A
Anal Chem; 2008 Nov; 80(22):8702-11. PubMed ID: 18847283
[TBL] [Abstract][Full Text] [Related]
26. High antitumor activity of highly resistant salan-titanium(IV) complexes in nanoparticles: an identified active species.
Meker S; Margulis-Goshen K; Weiss E; Magdassi S; Tshuva EY
Angew Chem Int Ed Engl; 2012 Oct; 51(42):10515-7. PubMed ID: 22961758
[TBL] [Abstract][Full Text] [Related]
27. Titanium(IV) complexes: cytotoxicity and cellular uptake of titanium(IV) complexes on caco-2 cell line.
Hernández R; Méndez J; Lamboy J; Torres M; Román FR; Meléndez E
Toxicol In Vitro; 2010 Feb; 24(1):178-83. PubMed ID: 19772913
[TBL] [Abstract][Full Text] [Related]
28. Cytotoxic salan-titanium(IV) complexes: high activity toward a range of sensitive and drug-resistant cell lines, and mechanistic insights.
Manna CM; Braitbard O; Weiss E; Hochman J; Tshuva EY
ChemMedChem; 2012 Apr; 7(4):703-8. PubMed ID: 22262543
[TBL] [Abstract][Full Text] [Related]
29. Insights into molecular mechanism of action of salan titanium(IV) complex with in vitro and in vivo anticancer activity.
Miller M; Braitbard O; Hochman J; Tshuva EY
J Inorg Biochem; 2016 Oct; 163():250-257. PubMed ID: 27090292
[TBL] [Abstract][Full Text] [Related]
30. Hydrolytically Stable and Cytotoxic [ONO
Pedko A; Rubanovich E; Tshuva EY; Shurki A
Inorg Chem; 2022 Nov; 61(44):17653-17661. PubMed ID: 36273341
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxicity and hydrolysis of trans-Ti(IV) complexes of salen ligands: structure-activity relationship studies.
Tzubery A; Tshuva EY
Inorg Chem; 2012 Feb; 51(3):1796-804. PubMed ID: 22220885
[TBL] [Abstract][Full Text] [Related]
32. Major impact of N-methylation on cytotoxicity and hydrolysis of salan Ti(IV) complexes: sterics and electronics are intertwined.
Meker S; Manna CM; Peri D; Tshuva EY
Dalton Trans; 2011 Oct; 40(38):9802-9. PubMed ID: 21874187
[TBL] [Abstract][Full Text] [Related]
33. Superstoichiometric Binding of the Anticancer Agent Titanocene Dichloride by Human Serum Transferrin and the Accompanying Lobe Closure.
Profitt LA; Baxter RHG; Valentine AM
Biochemistry; 2022 May; 61(9):795-803. PubMed ID: 35373558
[TBL] [Abstract][Full Text] [Related]
34. Probing the Mechanism of Action of Bis(phenolato) Amine (ONO Donor Set) Titanium(IV) Anticancer Agents.
Musa M; Abid M; Bradshaw TD; Boocock DJ; Coveney C; Argent SP; Woodward S
J Med Chem; 2024 Feb; 67(4):2732-2744. PubMed ID: 38331433
[TBL] [Abstract][Full Text] [Related]
35. Coordination Complexes of Titanium(IV) for Anticancer Therapy.
Tshuva EY; Miller M
Met Ions Life Sci; 2018 Feb; 18():. PubMed ID: 29394027
[TBL] [Abstract][Full Text] [Related]
36. Stereoselective formation of seven-coordinate titanium(IV) monomer and dimer complexes of ethylenebis(o-hydroxyphenyl)glycine.
Guo M; Sun H; Bihari S; Parkinson JA; Gould RO; Parsons S; Sadler PJ
Inorg Chem; 2000 Jan; 39(2):206-15. PubMed ID: 11272527
[TBL] [Abstract][Full Text] [Related]
37. Water-soluble titanocene complexes with sulfur-containing amino acids: synthesis, spectroscopic, electrochemical and Ti(IV)-transferrin interaction studies.
Pérez Y; López V; Rivera-Rivera L; Cardona A; Meléndez E
J Biol Inorg Chem; 2005 Mar; 10(2):94-104. PubMed ID: 15619089
[TBL] [Abstract][Full Text] [Related]
38. Cycloplatinated(II) Derivatives of Mercaptopurine Capable of Binding Interactions with HSA/DNA.
Aseman MD; Aryamanesh S; Shojaeifard Z; Hemmateenejad B; Nabavizadeh SM
Inorg Chem; 2019 Dec; 58(23):16154-16170. PubMed ID: 31721562
[TBL] [Abstract][Full Text] [Related]
39. Markedly different cytotoxicity of the two enantiomers of C(2)-symmetrical Ti(IV) phenolato complexes; mechanistic implications.
Manna CM; Tshuva EY
Dalton Trans; 2010 Feb; 39(5):1182-4. PubMed ID: 20104339
[TBL] [Abstract][Full Text] [Related]
40. Facile synthesis of [ONON] type titanium
Zhao T; Wang P; Liu N; Li S; Yang M; Yang Z
J Inorg Biochem; 2022 Oct; 235():111925. PubMed ID: 35839681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
